Toremifene for recurrent and advanced endometrial carcinoma
- 1 January 1992
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (10) , 1768
- https://doi.org/10.1016/0959-8049(92)90090-o
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer—Preliminary reportGynecologic Oncology, 1991
- Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers: Phase I studyJournal of Steroid Biochemistry, 1990
- Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II studyEuropean Journal of Cancer and Clinical Oncology, 1988
- ALTERNATIVE MECHANISM OF ACTION OF "ANTI-OESTROGENS" IN BREAST CANCERThe Lancet, 1987
- Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinomaGynecologic Oncology, 1987
- Tamoxifen and liver damage.BMJ, 1984
- Progestin Therapy of Endometrial, Breast and Ovarian CarcinomaActa Obstetricia et Gynecologica Scandinavica, 1984
- Reporting results of cancer treatmentCancer, 1981